Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW
Search ResultsShowing 1 - 2 of 2 results for "Ena Respiratory"
Super funds back COVID-19 preventative drug
KARREN VERGARA  |  THURSDAY, 7 JAN 2021
... forces with CSL, a venture capital fund and universities to fund medical research conducted by Melbourne-based Ena Respiratory. The superannuation funds' investment size was not disclosed by the company. Ena Respiratory has developed INNA-051, a nasal ...
Super-backed company develops COVID treatment
ALLY SELBY  |  WEDNESDAY, 30 SEP 2020
... preventative treatment shown to reduce COVID-19 levels by up to 96%. The product, INNA-051, is being developed by Ena Respiratory, and works by stimulating and boosting the innate immune system. The study found that boosting the immune system this way ...
PAGE:
1
Link to something rXGUYRN9